SCYX
Scynexis IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$58.10M
P/E Ratio
—
EPS
$-0.48
Beta
1.12
52W High
$1.31
52W Low
$0.56
50-Day MA
$0.91
200-Day MA
$0.80
Dividend Yield
—
Profit Margin
-120.50%
Forward P/E
3.72
PEG Ratio
0.00
About Scynexis Inc
SCYNEXIS, Inc., a biotechnology company, offers therapies for the treatment of yeast infections in the United States. The company is headquartered in Jersey City, New Jersey.
Fundamentals
| Revenue (TTM) | $20.34M |
| Gross Profit (TTM) | $20.34M |
| EBITDA | $-36.54M |
| Operating Margin | -120.00% |
| Return on Equity | -53.40% |
| Return on Assets | -21.00% |
| Revenue/Share (TTM) | $0.40 |
| Book Value | $0.67 |
| Price-to-Book | 1.41 |
| Price-to-Sales (TTM) | 2.86 |
| EV/Revenue | 0.0479 |
| EV/EBITDA | 0.05 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1809.00% |
| Shares Outstanding | $79.44M |
| Float | $57.60M |
| % Insiders | 1.96% |
| % Institutions | 42.33% |
Historical Volatility
HV 10-Day
82.23%
HV 20-Day
70.29%
HV 30-Day
70.08%
HV 60-Day
70.39%
HV Rank
47.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.19 target)
1
Strong Buy2
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026